Cabbacis Inc. CABI
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.34M | 1.13M | 922.40K | 882.90K | 843.40K |
| Depreciation & Amortization | 18.40K | 11.20K | 4.00K | 3.00K | 2.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.17M | 1.88M | 1.59M | 1.48M | 1.38M |
| Operating Income | -2.17M | -1.88M | -1.59M | -1.48M | -1.38M |
| Income Before Tax | -2.19M | -1.89M | -1.58M | -1.47M | -1.35M |
| Income Tax Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings from Continuing Operations | -2.19 | -1.89 | -1.58 | -1.47 | -1.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.19M | -1.89M | -1.58M | -1.47M | -1.35M |
| EBIT | -2.17M | -1.88M | -1.59M | -1.48M | -1.38M |
| EBITDA | -2.16M | -1.87M | -1.59M | -1.16M | -735.20K |
| EPS Basic | -0.31 | -0.27 | -0.24 | -0.23 | -0.21 |
| Normalized Basic EPS | -0.19 | -0.17 | -0.15 | -0.14 | -0.13 |
| EPS Diluted | -0.31 | -0.27 | -0.24 | -0.23 | -0.22 |
| Normalized Diluted EPS | -0.19 | -0.17 | -0.15 | -0.14 | -0.13 |
| Average Basic Shares Outstanding | 28.52M | 27.56M | 26.61M | 25.89M | 25.17M |
| Average Diluted Shares Outstanding | 28.52M | 27.56M | 26.61M | 25.89M | 25.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |